Clinical Scorecard: Optimizing Exercise Interventions for Pain Relief in Breast Cancer Survivors: A Systematic Review and Dose-Response Network Meta-Analysis

At a Glance

Key Highlights

• Approximately 42% of breast cancer survivors experience chronic pain related to cancer or its treatments.
• Pharmacological pain management (NSAIDs, opioids) may be ineffective or have adverse effects, necessitating non-pharmacological alternatives.
• Dose-response network meta-analysis identifies optimal exercise modalities and dosages tailored for pain relief in breast cancer survivors.

Guideline-Based Recommendations

Diagnosis

• Assess pain using validated scales such as the Visual Analogue Scale throughout the cancer continuum.

Management

• Incorporate exercise interventions as a non-pharmacological approach to pain management.
• Follow evidence-based exercise prescriptions specifying type, frequency, intensity, and duration tailored to breast cancer survivors.
• Consider comprehensive physical therapy approaches including massage and acupuncture as per NCCN guidelines, though exercise specifics require further guidance.

Monitoring & Follow-up

• Monitor pain levels pre- and post-exercise intervention using validated pain assessment tools.
• Adjust exercise dose to avoid exacerbation of symptoms given survivors’ vulnerable physiological status.

Risks

• Be cautious of inappropriate exercise dosages that may worsen symptoms.
• Consider potential side effects and addiction risks associated with long-term opioid use.

Patient & Prescribing Data

Adult female breast cancer survivors who have completed primary cancer treatments.

Exercise interventions show promise for pain relief with minimal side effects; optimal dosing is critical to maximize benefits and minimize risks.

Clinical Best Practices

• Use a tailored, evidence-based exercise prescription specific to pain management in breast cancer survivors.
• Employ a dose-response approach to determine optimal exercise modality and dosage.
• Ensure exercise interventions are standalone or matched in control groups to isolate exercise effects.
• Utilize randomized controlled trial data to guide clinical decision-making.

References

• Global breast cancer incidence data 2023
• NCCN Adult Cancer Pain Management Guidelines
• PRISMA-NMA Reporting Guidelines
• PROSPERO Registration CRD420251145348